PLI schemes should also focus on entities supporting production of branded pharma products: Bharat Biotech

PLI schemes should also focus on entities supporting production of branded pharma products: Bharat Biotech Currently, the government through the Department of Pharmaceuticals (DoP) is currently implementing three PLI schemes -- Bulk Drugs (Rs 6,940 crore), Medical Devices (Rs 3,420 crore) and Pharmaceuticals (Rs 15,000 crore) -- to promote manufacturing activity. Prasad noted that the domestic pharma sector should "focus upon innovation." https://ift.tt/ZInpjJX

Comments

Popular posts from this blog

Nadda reviews healthcare delivery mechanisms in Rajasthan, Maharashtra

Women in India Report Higher Sleep Deprivation Than Men

Capping MBBS seats by NMC deferred for academic years 2024-25, 2025-26: Nadda